PMC:7405836 / 101697-101998 JSONTXT

Annnotations TAB JSON ListView MergeView

LitCovid-PD-FMA-UBERON

Id Subject Object Predicate Lexical cue fma_id
T3 146-150 Body_part denotes cell http://purl.org/sig/ont/fma/fma68646
T4 227-231 Body_part denotes cell http://purl.org/sig/ont/fma/fma68646

LitCovid-PD-MONDO

Id Subject Object Predicate Lexical cue mondo_id
T917 34-42 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T918 34-38 Disease denotes SARS http://purl.obolibrary.org/obo/MONDO_0005091

LitCovid-PD-CLO

Id Subject Object Predicate Lexical cue
T6 45-53 http://purl.obolibrary.org/obo/CLO_0001658 denotes activity
T7 120-125 http://purl.obolibrary.org/obo/NCBITaxon_10239 denotes virus
T8 146-150 http://purl.obolibrary.org/obo/GO_0005623 denotes cell
T9 227-231 http://purl.obolibrary.org/obo/GO_0005623 denotes cell

LitCovid-PD-CHEBI

Id Subject Object Predicate Lexical cue chebi_id
T29307 103-108 Chemical denotes drugs http://purl.obolibrary.org/obo/CHEBI_23888
T17949 152-157 Chemical denotes drugs http://purl.obolibrary.org/obo/CHEBI_23888
T45023 237-242 Chemical denotes drugs http://purl.obolibrary.org/obo/CHEBI_23888

LitCovid-PD-GO-BP

Id Subject Object Predicate Lexical cue
T3 120-150 http://purl.obolibrary.org/obo/GO_0046718 denotes virus entry into the host cell
T4 169-186 http://purl.obolibrary.org/obo/GO_0019079 denotes viral replication
T5 169-186 http://purl.obolibrary.org/obo/GO_0019058 denotes viral replication
T6 279-294 http://purl.obolibrary.org/obo/GO_0006955 denotes immune response

LitCovid-sentences

Id Subject Object Predicate Lexical cue
T701 0-301 Sentence denotes Therapeutic agents that have anti-SARS-CoV-2 activity can be broadly classified into three categories: drugs that block virus entry into the host cell, drugs that block viral replication as well as its survival within the host cell, and drugs that attenuate the exaggerated host immune response (300).

LitCovid-PubTator

Id Subject Object Predicate Lexical cue tao:has_database_id
2741 34-44 Species denotes SARS-CoV-2 Tax:2697049